trial
as of 2026-07-01Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia
NCTId NCT05599373
at a glance
— · Unknown
Enrollment 90 (estimated)
Sponsored by Shanghai Mental Health Center
Primary completion 2023-12-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2020-01-01
Primary completion
2023-12-31
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Drugs
Sponsors
Shanghai Mental Health CenterLead Sponsor
Xuhui Mental Health CenterCollaborator
Investigators
1
Yan Zhan, MDPrincipal Investigator
Sites
1 total
Shanghai, China
Facts & assertions
4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2023-12-31
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
indication
indication
investigator
person